Biohaven’s Life Without CGRP Inhibitors Gets Off To A Rocky Start

Data Mixed In Spinocerebellar Ataxia Study, But Zavegepant PDUFA Date Set

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.